Is Stereotaxis Stock a Good Investment?
Stereotaxis Investment Advice | STXS |
- Examine Stereotaxis' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Stereotaxis' leadership team and their track record. Good management can help Stereotaxis navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Stereotaxis' business and its evolving consumer preferences.
- Compare Stereotaxis' performance and market position to its competitors. Analyze how Stereotaxis is positioned in terms of product offerings, innovation, and market share.
- Check if Stereotaxis pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Stereotaxis' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Stereotaxis stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Stereotaxis is a good investment.
Sell | Buy |
Hold
Market Performance | Insignificant | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Stereotaxis Stock
Researching Stereotaxis' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 16.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.27. Stereotaxis had not issued any dividends in recent years. The entity had 1096:1000 split on the 4th of November 2013.
To determine if Stereotaxis is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Stereotaxis' research are outlined below:
| Stereotaxis had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 26.77 M. Net Loss for the year was (20.71 M) with profit before overhead, payroll, taxes, and interest of 18.47 M. | |
| Stereotaxis currently holds about 30.94 M in cash with (9.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
| Roughly 16.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference |
Stereotaxis uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Stereotaxis. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Stereotaxis' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 1st of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 1st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Stereotaxis' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Stereotaxis' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-11-09 | 2023-09-30 | -0.06 | -0.07 | -0.01 | 16 | ||
2023-05-09 | 2023-03-31 | -0.06 | -0.07 | -0.01 | 16 | ||
2023-03-03 | 2022-12-31 | -0.07 | -0.06 | 0.01 | 14 | ||
2022-11-10 | 2022-09-30 | -0.06 | -0.07 | -0.01 | 16 | ||
2022-08-09 | 2022-06-30 | -0.06 | -0.07 | -0.01 | 16 | ||
2021-05-10 | 2021-03-31 | -0.03 | -0.02 | 0.01 | 33 | ||
2021-02-25 | 2020-12-31 | -0.03 | -0.02 | 0.01 | 33 | ||
2024-08-12 | 2024-06-30 | -0.05 | -0.07 | -0.02 | 40 |
Stereotaxis' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 202.5 M.Market Cap |
|
Stereotaxis' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.49) | (0.52) | |
| Return On Capital Employed | (0.76) | (0.72) | |
| Return On Assets | (0.49) | (0.52) | |
| Return On Equity | (0.94) | (0.99) |
Determining Stereotaxis' profitability involves analyzing its financial statements and using various financial metrics to determine if Stereotaxis is a good buy. For example, gross profit margin measures Stereotaxis' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Stereotaxis' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Stereotaxis' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Stereotaxis. Check Stereotaxis' Beneish M Score to see the likelihood of Stereotaxis' management manipulating its earnings.
Evaluate Stereotaxis' management efficiency
Stereotaxis has return on total asset (ROA) of (0.2935) % which means that it has lost $0.2935 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0646) %, meaning that it created substantial loss on money invested by shareholders. Stereotaxis' management efficiency ratios could be used to measure how well Stereotaxis manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.52 in 2024. Return On Capital Employed is likely to gain to -0.72 in 2024. At this time, Stereotaxis' Other Current Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 38.5 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 4.7 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.27 | 0.26 | |
| Tangible Book Value Per Share | 0.27 | 0.26 | |
| Enterprise Value Over EBITDA | (5.97) | (6.27) | |
| Price Book Value Ratio | 6.44 | 7.32 | |
| Enterprise Value Multiple | (5.97) | (6.27) | |
| Price Fair Value | 6.44 | 7.32 | |
| Enterprise Value | 126.9 M | 110.4 M |
The management strategies employed by Stereotaxis' are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Beta 1.551 |
Basic technical analysis of Stereotaxis Stock
As of the 2nd of December, Stereotaxis has the Risk Adjusted Performance of 0.0435, coefficient of variation of 2161.05, and Semi Deviation of 2.92. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Stereotaxis, as well as the relationship between them. Please validate Stereotaxis semi deviation, jensen alpha, as well as the relationship between the Jensen Alpha and semi variance to decide if Stereotaxis is priced more or less accurately, providing market reflects its prevalent price of 2.39 per share. Please also confirm Stereotaxis total risk alpha, which is currently at (0.51) to double-check the company can sustain itself at a future point.Stereotaxis' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Stereotaxis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Stereotaxis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Stereotaxis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Stereotaxis' Outstanding Corporate Bonds
Stereotaxis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Stereotaxis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Stereotaxis bonds can be classified according to their maturity, which is the date when Stereotaxis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| STE 375 15 MAR 51 Corp BondUS85917PAB31 | View | |
| STE 27 15 MAR 31 Corp BondUS85917PAA57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Stereotaxis' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Stereotaxis' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0435 | |||
| Market Risk Adjusted Performance | 0.2477 | |||
| Mean Deviation | 2.61 | |||
| Semi Deviation | 2.92 | |||
| Downside Deviation | 3.33 | |||
| Coefficient Of Variation | 2161.05 | |||
| Standard Deviation | 4.15 | |||
| Variance | 17.2 | |||
| Information Ratio | 0.0131 | |||
| Jensen Alpha | 0.0842 | |||
| Total Risk Alpha | (0.51) | |||
| Sortino Ratio | 0.0163 | |||
| Treynor Ratio | 0.2377 | |||
| Maximum Drawdown | 27.16 | |||
| Value At Risk | (5.64) | |||
| Potential Upside | 5.5 | |||
| Downside Variance | 11.11 | |||
| Semi Variance | 8.51 | |||
| Expected Short fall | (3.27) | |||
| Skewness | 2.34 | |||
| Kurtosis | 11.62 |
| Risk Adjusted Performance | 0.0435 | |||
| Market Risk Adjusted Performance | 0.2477 | |||
| Mean Deviation | 2.61 | |||
| Semi Deviation | 2.92 | |||
| Downside Deviation | 3.33 | |||
| Coefficient Of Variation | 2161.05 | |||
| Standard Deviation | 4.15 | |||
| Variance | 17.2 | |||
| Information Ratio | 0.0131 | |||
| Jensen Alpha | 0.0842 | |||
| Total Risk Alpha | (0.51) | |||
| Sortino Ratio | 0.0163 | |||
| Treynor Ratio | 0.2377 | |||
| Maximum Drawdown | 27.16 | |||
| Value At Risk | (5.64) | |||
| Potential Upside | 5.5 | |||
| Downside Variance | 11.11 | |||
| Semi Variance | 8.51 | |||
| Expected Short fall | (3.27) | |||
| Skewness | 2.34 | |||
| Kurtosis | 11.62 |
Consider Stereotaxis' intraday indicators
Stereotaxis intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Stereotaxis stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Stereotaxis Corporate Filings
10Q | 14th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 6th of September 2024 Other Reports | ViewVerify | |
| 23rd of August 2024 Other Reports | ViewVerify |
Stereotaxis Stock media impact
Far too much social signal, news, headlines, and media speculation about Stereotaxis that are available to investors today. That information is available publicly through Stereotaxis media outlets and privately through word of mouth or via Stereotaxis internal channels. However, regardless of the origin, that massive amount of Stereotaxis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Stereotaxis news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Stereotaxis relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Stereotaxis' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Stereotaxis alpha.
Stereotaxis Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Stereotaxis can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Stereotaxis Corporate Management
| Nathan Kastelein | RD Concepts | Profile | |
| John Platt | Director Software | Profile | |
| Brian Kidd | RD Devel | Profile | |
| Laura Garth | General Secretary | Profile | |
| Keith Galloway | Vice Operations | Profile |
Additional Tools for Stereotaxis Stock Analysis
When running Stereotaxis' price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.